Pharmaceutical Supply – Levetiracetam for Injection

The contract requires the supply and delivery of 2,000 PG units of Levetiracetam for Injection, a sterile anticonvulsant medication, to meet the stringent pharmaceutical standards mandated by the Department of Defense. The product must comply with FDA current Good Manufacturing Practices and be labeled in accordance with National Stock Number and National Drug Code requirements, ensuring proper identification and traceability within military health systems. Packaging must adhere to Department of Defense specifications to guarantee integrity, security, and compatibility with logistical operations across all deployment environments. Delivered under a subcontract issued by the Defense Logistics Agency, the contract is categorized under NAICS code 325412 for pharmaceutical and biological product manufacturing. The award is tied to contract SPE2DX25D9822 with delivery reference SPE2D226F3043, and fulfillment is expected to support defense medical readiness. Although specific delivery locations or point of contact details are not provided, the procurement is structured to align with the DoD’s pharmaceutical supply chain protocols, emphasizing quality control, regulatory compliance, and readiness for rapid deployment in operational or emergency scenarios.